HIGHLIGHTS
SUMMARY
Obstructive sleep_apnea (OSA) is a condition in which the upper airway is partially or completely blocked during sleep, resulting in arterial oxygen desaturation and arousals. By comparing its efficacy to MAD, this study intends to introduce this new oral appliance, CMOA, in controlling OSA as a unique remedial choice for individuals suffering from mild OSA. Basyuni has stated in their article which was an update on MAD as a therapy for obstructive sleep_apnea syndrome that studies since 2005 on managing OSA with MAD have revealed a reduction in mean AHI between 30 and 72 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.